Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glibenclamide in large hemispheric infarction (Japan extension of NCT02864953)
jRCT2080224029Phase 3Terminated
- Sponsor
- Biogen
- Start
- Aug 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in brain infarction and cerebral edema comparing Glibenclamide with Placebo (2 arms). Started Aug 2018; status: terminated.
02
Drugs
glibenclamide
03
Conditions
brain infarctioncerebral edema
Beyond the preview
Go deeper on jRCT2080224029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224029.